Evidence map›Paper›PMID 14966559›Full record

ArticleThe Journal of clinical investigation2004

HDL action on the vascular wall: is the answer NO?

Philip W Shaul, Chieko Mineo

Abstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. HDL Composition, Heart Failure, and Its Comorbidities.Frontiers in cardiovascular medicine · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Apo a-I modulating therapies.Current cardiology reports · 2011
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Philip W ShaulDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. philip.shaul@utsouthwestern.edu
Chieko Mineo
Pediatrics and Genetics · USThe University of Texas Southwestern Medical Center · US

Funding

REGULATION OF NITRIC OXIDE SYNTHASE IN DEVELOPING LUNGR01HD030276 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W · 1993 to 2010
$3.1M
CHOLESTEROL AND ENDOTHELIAL NO SYNTHASE TRAFFICKINGR01HL058888 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W · 1997 to 2007
$1.9M
REGULATION OF CYCLOOXYGENASE GENES IN DEVELOPING LUNGR01HL053546 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI SHAUL, PHILIP W · 1995 to 2003
$1.2M
NHLBI NIH HHS HL30276NHLBI NIH HHS HL53546NHLBI NIH HHS HL58888NHLBI NIH HHS R01 HL058888NICHD NIH HHS R01 HD030276
6 · The paper itself

Abstract

Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

Indexed as

AnimalsArteriosclerosisCholesterol, HDLEndothelium, VascularHumansNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIISignal TransductionCholesterol, HDLNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIINOS3 protein, human

Identifiers

PMID14966559
PMCPMC338271
OpenAlexW1969135621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.